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Abstract Infection of the central nervous system with
human immunodeficiency virus type 1 (HIV-1) can produce
morphological changes in the neocortical synaptodendritic
arbor that are correlated with neurocognitive impairment.
To determine whether HIV-1 infection influences the
protein composition of human synapses, a proteomic study
of isolated nerve endings was undertaken. Synaptosomes
from frontal neocortex were isolated using isopyknic
centrifugation from 19 human brain specimens. Purity and
enrichment were assessed by measuring pre- and postsyn-
aptic protein markers. Two-dimensional polyacrylamide gel
electrophoresis and matrix-assisted laser desorption ioniza-
tion time-of-flight mass spectrometry was used to screen for
proteins differentially expressed in HIV/AIDS. The con-
centrations of 31 candidate protein spots were potentially
abnormal in HIV-infected decedents with HIV encephalitis
and/or increased expression of immunoproteasome sub-
units. Immunoblots showed that the concentration of some
of them was related to HIV-1 infection of the brain and
immunoproteasome (IPS) induction. Synapsin 1b and
stathmin were inversely related to brain HIV-1 load; 14-3-
3ζ and 14-4-4ε proteins were higher in subjects with HIV-1
loads. Perturbed synaptosome proteins were linked with
IPS subunit composition, and 14-3-3ζ was histologically
colocalized with IPS subunits in stained neocortical
neurons. Proteomics illustrates that certain human proteins
within the synaptic compartment are involved with changes
in the synaptodendritic arbor and neurocognitive impair-
ment in HIV-1-infected people.
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Introduction
Infection with the human immunodeficiency virus type 1
(HIV-1) produces HIV-associated neurocognitive impairment
(HAND) in a high proportion of subjects (Sacktor et al.
2001). Prior to the era of highly active antiretroviral therapy
(HAART) in the USA, the prevalence of severe impairment
was about 20%. After HAART, the severity of HAND was
decreased very substantially, but its prevalence did not
decrease. Fewer than 5% of HAART-treated clinical cohorts
have outright dementia (McArthur 2004). The presumptive
neuropathological substrate in some, but not all people with
severe HAND is HIVencephalitis (HIVE; Glass et al. 1995;
Wiley and Achim 1994). In HIVE, there is increased
replication of HIV-1 in CNS glia, but not neurons, which
leads to inflammation and morphological changes in neural
elements (Kaul et al. 2001), including synapses, dendrites
(Masliah et al. 1997), and axons (Giometto et al. 1997).
Changes in the synaptodendritic arbor are potentially
important because they are correlated significantly with
HAND (Masliah et al. 1997). It is not clear whether
abnormal neocortical synapses in HIVE represent irreversible
neurodegeneration or instead reflect reversible physiological
plasticity. Physiological plasticity of synapses and the
concentration of synaptic proteins are both influenced locally
in the synaptic compartment by the ubiquitin–proteasome
system (UPS). The UPS is a main route of synaptic protein
degradation, and it plays a central role in regulating the
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plasticity and the minute-to-minute regulation of synaptic
physiology (Bingol and Schuman 2005; Patrick 2006;Y ia n d
Ehlers 2005). Disturbances of the UPS influence the synaptic
protein economy and lead to morphological changes in the
synaptodendritic compartment and physiological changes in
synaptic transmission (Hegde 2004). For example, inhibition
of UPS enzyme active sites (Fonseca et al. 2006)o r
exchanging UPS active sites with immunoproteasome (IPS)
subunits (Gavilan et al. 2009; Maher et al. 2006)b o t h
produce an immediate disturbance of synaptic long term
depression. In support of a potential role of HIV-1 on the
UPS, it has been demonstrated histochemically and neuro-
chemically that subjects with HAND accumulate ubiquitiny-
lated protein conjugates in association with decreased
synaptic protein (Gelman and Schuenke 2004). To further
elucidate biochemical changes of proteins in the synaptic
compartment in HIV/AIDS, we isolated nerve endings from
brain neocortex (cerebrocortical synaptosomes) and per-
formed a proteomic screening of synaptic proteins. The
concentrations of certain synaptic proteins in the isolated
nerve endings were related to replicating HIV-1 in the brain
and induction of IPS subunit expression. These new
observations provide increased support for the hypothesis
that HIV-1 infection perturbs the protein economy of the
synaptic compartment by modulation of the UPS.
Materials and methods
Subjects Nineteen brain specimens from the National
NeuroAIDS Tissue Consortium collection were used
(Morgello et al. 2001). All subjects except for three
uninfected normal control decedents had neuropsycholog-
ical evaluations prior to death and underwent a complete
autopsy and banking of the brain. All had natural deaths.
Subjects and next-of-kin gave informed consent in accor-
dance with statutes in the State of Texas in the USA.
Protection of human subjects was regulated by the
institutional review board at the University of Texas
Medical Branch at Galveston. Neurocognitive performance
was assessed in the HIV-1-infected subjects using a battery
of tests (Morgello et al. 2001). The subjects were
consolidated for confirmation studies using Western blot-
ting as follows: normal brain not infected with HIV (n=3),
HIV-infected with low brain HIV-1 and low IPS concen-
tration (n=8), and HIV-infected with high HIV-1 and high
IPS (n=8). In the group with high HIV-1 and IPS, four of
the subjects had HIVE and four did not. Concentrations of
HIV-1 RNA in brain cortex in the three respective groups
(log10 copies per gram of wet weight) were 0±0, 2.77±
1.50, and 4.81±0.48 (t test: p=0.0000055, low versus
high). The values for the IPS subunit LMP7 concentration
in the three groups were 1.00±0.79, 2.02±1.02, and 4.03±
2.15 (t test: p=0.0315, low versus high).
In the screening stage, these 19 samples were arranged
into seven groups of pooled specimens to undertake two-
dimensional polyacrylamide gel electrophoresis (2D-
PAGE). These multiple groupings were designed to insure
that we would account for potential influences of CNS
impairment (HAND), IPS induction, and HIVE in at least
one independent comparison. All seven of the synaptosome
pools were produced with equal contributions of protein
from its component samples as follows: pool A, normal
HIV-negative subjects (n=3); pool B, HIV-positive subjects
without HAND (n=3); pool C, HIV-positive subjects with
HAND but without HIVE (n=3); pool D, HIV-positive
subjects with HAND and HIVE (n=3); pool E, HIV-
positive with low IPS expression (n=3); pool F, HIV-
positive with high IPS and no HIVE (n=3); and pool G,
HIV-infected with high IPS and HIVE (n=4). To cover all
of the desired comparisons in the screening stage, a few
synaptosome isolates were used in more than one pool.
Seven gels for pools A through G were each analyzed in
triplicate on 2D-PAGE. Computerized analysis of digital
images of the 21 gels was performed to compare spot
intensities between groups, which are as follows: A versus
B, B versus C, B versus D, C versus D, E versus F, E
versus G, and F versus G. After these preliminary
comparisons were done and candidate spots were identified
(see below), synaptosome isolates from each of the 19
subjects were then collapsed into three main groups
described above to undertake confirmatory studies using
Western blotting.
Synaptosome isolation About 500 mg of dorsolateral
prefrontal cortex from Brodmann area 9 was dissected free
while frozen. Synaptosomes were isolated at 4°C by
differential centrifugation in a discontinuous sucrose gradi-
ent using a standard procedure (Dodd et al. 1981; Eshleman
et al. 2001; Gray and Whittaker 1962; Mash et al. 2002;
Wood et al. 1996). Specimens were thawed briefly and
added to 5 mL of ice cold buffered sucrose (0.32 M
sucrose, 5 mM HEPES, 25 μL protease inhibitor cocktail
(Sigma Aldrich), and 50 μL phosphatase inhibitor cocktail
(EMD Chemicals, Inc., Gibbstown, NJ, USA), pH7.4).
They were homogenized with eight strokes in a Potter–
Elvehjem tissue grinder with 0.1 to 0.5 mm tolerance
(Fisher Scientific), with intermittent immersion in an ice
bath for 30 s between strokes. Homogenates were centri-
fuged at 1,000×g for 10 min at 4°C to yield a crude pellet
(P1a) and supernatant (S1a). P1a was washed and centri-
fuged as above, yielding a second pellet (P1b) and
supernatant (S1b). The supernatants were combined into
S1, brought to a volume of 10 mL, and centrifuged at
10,000×g for 20 min at 4°C to produce the P2 pellet. The
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layered over a discontinuous gradient composed of 2.5 mL
each of buffered sucrose with concentrations of 0.8, 1.0,
and 1.2 M from top to bottom. P2 was centrifuged at
150,000×g for 2 h at 4°C. The P3 synaptosome fraction
was collected from the interface of the 1.0- and 1.2-M
layers. P3 was washed in 0.32 M buffered sucrose at
150,000×g for 30 min at 4°C. The P3 pellet was collected
and stored frozen until use. The relative enrichment of
synaptic protein markers and depletion of glial markers in
these synaptosome isolates was compared to the starting
homogenate using Western blotting of pre- and postsynap-
tic protein markers, as listed in Fig. 1.
Proteomic screening Synaptosomes were pooled into the
seven groups, and then 2D-PAGE was performed in
triplicate in the proteomics core laboratory at the University
of Texas Medical Branch (http://www.utmb.edu/brf/). Iso-
electric focusing was done in the first dimension and
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) in the second dimension. Gels were stained
with SYPRO Red and photographed, and images were
analyzed by Nonlinear Dynamics Progenesis SameSpots
software (Nonlinear USA, Inc, Durham, NC, USA). Spots
with at least a 2-fold difference in averaged optical density
were considered further. Spots that had low intensity, were
part of a streak, or were not present in at least two gels were
eliminated. The gel with the highest spot intensity was
selected for manual excision for evaluation by mass
spectrometry using a large-bore pipette tip.
Mass spectrometry Gel spot samples were cut into 1-mm-
size pieces or smaller and placed into separate 0.5 mL
polypropylene tubes; 100 μL of 50 mm ammonium
bicarbonate buffer was added to each tube, and the samples
were incubated at 37°C for 30 min. The buffer was
removed, and 100 μL of water was then added to each
tube. The samples were incubated again at 37°C for 30 min,
water was removed, and 100 μL of acetonitrile was added
to dehydrate the gel pieces. After 5 min, the acetonitrile was
removed, and 100 μL of acetonitrile was again added and
removed. Excess solvent was removed in a Speedvac for
45 min and then 2 mL of 25 mM ammonium bicarbonate at
pH8.0 was added to a 20-μg vial of lyophilized trypsin
(Promega Corporation, Madison, WI, USA). The trypsin
solution was added to the sample, and they were digested at
37°C for 6 h. One microliter of sample solution was spotted
directly onto a matrix-assisted laser desorption ionization
(MALDI) target plate and allowed to dry. One microliter of
alpha-cyano-4-hydroxycinnamic acid (Sigma Aldrich) ma-
trix solution (50:50 acetonitrile/water at 5 mg/mL) was then
applied on the sample spot and allowed to dry. The dried
MALDI spot was blown with compressed air (Decon
Laboratories, Inc, King of Prussia, PA, USA) before mass
spectrometry.
MALDI time-of-flight mass spectrometry (TOF-MS)
w a su s e dt oo b t a i np r o t e i nidentification. Data were
acquired with an Applied Biosystems 4800 MALDI TOF/
TOF Proteomics Analyzer (Applied Biosystems, Foster
City, CA, USA). Applied Biosystems software package
included 4000 Series Explorer (v. 3.6 RC1) with Oracle
Database Schema Version (v. 3.19.0), Data Version (3.80.0)
to acquire both MS and MS/MS spectral data. The
instrument was operated in positive ion reflectron mode,
mass range was 850–3,000 Da, and the focus mass was set
at 1,700 Da. For MS data, 1,000–2,000 laser shots were
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Fig. 1 Immunoblots show that
human cerebrocortical synapto-
some preparations from frontal
neocortex specimens of eight
human subjects are enriched
with synaptic marker proteins. a
The immunoproteasome subunit
LMP7 was increased in synap-
tosomes from the HIV-positive
subjects. Pre- (b) and postsyn-
aptic (c) marker proteins were
enriched in synaptosomes by up
to 7-fold when compared to
unfractionated homogenates. d
Marker proteins for non-neural
cells, including mononuclear
phagocytes (CD68) and astro-
cytes (GFAP) were sharply de-
pleted in these synaptosome
isolates. See Table 1 for added
description of the proteins
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external calibration was performed using a peptide mixture
with reference masses 904.468, 1,296.685, 1,570.677, and
2,465.199.
MALDI MS/MS was performed on several (five to 10)
abundant ions from each sample spot. A 1-kV positive ion,
MS/MS method was used to acquire data under postsource
decay (PSD) conditions. The instrument precursor selection
window was ±3 Da. For MS/MS data, 2,000 laser shots were
acquired and averaged from each sample spot. Automatic
external calibration was performed using reference fragment
masses 175.120, 480.257, 684.347, 1,056.475, and
1,441.635 (from precursor mass 1,570.700). Applied Bio-
systems GPS Explorer
TM (v. 3.6) software was used in
conjunction with MASCOT to search the respective protein
database using both MS and MS/MS spectral data for protein
identification. Protein match probabilities were determined
using expectation values and/or MASCOT protein scores.
MS peak filtering included the following parameters: mass
range 800 to 3,000 Da, minimum S/N filter=10, mass
exclusion list tolerance=0.5 Da, and mass exclusion list (for
some trypsin and keratin-containing compounds) included
masses 842.51, 870.45, 1,045.56, 1,179.60, 1,277.71,
1,475.79, and 2,211.1. For MS/MS peak filtering, the
minimum S/N filter=10.
For protein identification, the human taxonomy was
searched in the database. Other conditions used included
selection of trypsin as the digesting enzyme, the maximum
missed cleavages was =1, a fixed modification was
carbamidomethyl (C) for 2-D gel analyses only, a variable
modifications was oxidation (M), precursor tolerance was
set at 0.2 Da, MS/MS fragment tolerance was set at 0.3 Da,
mass=monoisotopic, and peptide charges were only con-
sidered as +1. The significance of a protein match, based on
both the peptide mass fingerprint in the first MS and the
MS/MS data from several precursor ions, was based on
expectation values; each protein match was accompanied
by an expectation value. The expectation value was the
number of matches with equal or better scores that were
expected to occur by chance alone. The default significance
threshold was p<0.05 (an expectation value of 0.05 is
considered to be on this threshold). A more stringent
threshold of 10
−3 for protein identification was used; the
lower the expectation value, the more significant the score.
Western blotting Total protein (10−30 μg) in 15 μL volume
of synaptosome or earlier fractions was added to 15 μLo f
2× Laemmli sample buffer (Bio-Rad Laboratories) with 5%
beta-mercaptoethanol in 1.5 mL microcentrifuge tubes and
boiled for 5 min. Samples were then loaded into Criterion
Precast 18-well 5%, 15%, or 4–20% gradient Tris–HCL
gels (Bio-Rad Laboratories) for SDS-PAGE to run for
approximately 1 h at 180 V. Proteins were transferred to
polyvinylidene fluoride membrane (Amersham Biosciences,
Piscataway, NJ, USA) for 3 h at 60 V in 4°C. Membranes
were blocked with 5% nonfat dry milk in TBST (0.05 M
Trizma–HCl, 0.15 M NaCl, and 0.1% Tween 20) for 1 h and
then incubated overnight with primary antibody (Table 1)
diluted in TBST according to the antibody supplier data
sheet. Membranes were then washed three times for 5 min
with TBST and incubated with the appropriate anti-rabbit or
anti-mouse secondary antibody diluted 1:5,000 for 1 h
(Amersham Biosciences). After washing, Enhanced Chemi-
luminescence Detection Reagent (Amersham Biosciences)
was applied for 2 min, and the membrane was exposed to
Kodak BioMAX XAR film (Rochester, NY, USA) for 30 s
to 3 min, depending upon signal intensity. The film was
developed and digitized by computer scanner, and band
density was quantified using One-Dscan (BD Biosciences
Bioimaging, Rockville, MD, USA).
Immunofluorescence microscopy Paraffin-embedded sec-
tions of dorsolateral prefrontal cortex from subjects with
HIVE and controls were used. Antigen retrieval was
performed in sodium citrate buffer using a preheated
vegetable steamer for 20 min. Sections were cooled and
then blocked with Image-iT FX signal enhancer (Invitrogen
Molecular Probes, Eugene, OR, USA) for 30 min, followed
by blocking with 5% bovine serum albumin plus 5%
normal goat serum in TBST for 1 h. Primary antibodies
(Table 1) were diluted in blocking solution and applied
overnight at 4°C. Slides were incubated for 1 h with the
appropriate Alexa-Fluor fluorochrome-conjugated second-
ary antibody (Invitrogen Molecular Probes) diluted in
blocking solution. To block autofluorescence, sections were
incubated with Sudan Black B (Sigma Aldrich) solution
(1% Sudan Black B in 70% ethanol) for 10 min. After
washing, coverslips were mounted using Slow Fade Gold
withDAPI (Invitrogen Molecular Probes)mountingmedium.
Laser confocal microscopy was performed with a Zeiss
LSM 510 UV META laser scanning confocal microscope
consisting of an Axiovert 200 M Inverted Microscope
equipped with an oil-immersion ×100 resolution objective
for fluorescence, Ar, dual HeNe, and UV lasers and
fluorescence filters set for DAPI, FITC, TRITC, and far
red, a scanning module with visible and UVacousto optical
tunable filters, two independent fluorescence channels
(2 PMTs), and a 32-PMT array (Carl Zeiss MicroImaging,
Inc, Thornwood, NY, USA).
HIV-1 RNA concentration Detection of the HIV-1 envelope
protein in mRNA extracts from brain tissue was performed
using a modification of a single copy procedure (Palmer et
al. 2003). HIV RNA from frontal neocortex was extracted
using RNeasy Lipid Tissue Mini Kit (Qiagen, Valencia,
CA, USA). One microgram of brain RNA and 1 μmol/L of
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cDNA Synthesis Kit, Bio-Rad, Hercules, CA, USA). Four
microliters of cDNA was used for a 25 μL real-time PCR
using JumpStart Taq ReadyMix (Sigma, Saint Louis, MO,
USA) and SmartCycler (Cepheid, Sunnyvale, CA, USA).
Results were standardized against a known brain secondary
standard and expressed according to wet weights. Cerebro-
spinal fluid (CSF) and blood plasma HIV-1 RNA concen-
tration (copies per milliliter) was measured using the
Amplicor HIV-1 Monitor® Test (Roche Diagnositics Inc.,
Indianapolis, IN, USA).
Statistics Data were compiled and analyzed using Microsoft
Excel 2003 (Microsoft Corporation, Redmond, Washington,
DC, USA) and GraphPad InStat Version 3.06 (GraphPad
Software, Inc., La Jolla, CA, USA). Student’s t test was
performed in Microsoft Excel 2003 to determine differences
between two groups. Comparisons between three or more
groups were performed by analysis of variance (ANOVA)
with posttest analyses in GraphPad Instat. Data were tested
for Gaussian distribution by the method of Kolmogorov and
Smirnov. If the data were considered normal, one-way
ANOVA was performed, followed by the Tukey–Kramer
multiple comparisons test. Data that did not pass the
normality test were analyzed by the Kruskal–Wallis test
(non-parametric ANOVA) followed by Dunn's multiple
comparisons test. Analysis of correlation and regression
was performed in Microsoft Excel. Graphs were produced in
Microsoft Excel 2003. Where applicable, error bars represent
an approximation of the standard error of the mean by the
95% confidence intervals.
Results
Protein composition of human synaptosome isolates All
human brain neocortical specimens were frozen at −80°C
prior to isolation of synaptosomes, except in preliminary
experiments to compare protein yields using freshly
obtained brain specimens and/or cryoprotected and rapidly
thawed brain specimens from the same individual. The
distribution and the enrichment of synaptic protein markers
Antibody (clone) Source Product ID Species Type Dilution
Immunoblotting
Synaptophysin (SVP-38) Sigma Aldrich S5768 Mouse Monoclonal 1:5,000
GAP43 (GAP-7B10) Sigma Aldrich G9264 Mouse Monoclonal 1:4,000
LMP7/β5i (LMP7-1) Biomol PW8845 Mouse Monoclonal 1:1,000
Dynamin 1 (D5) Millipore MAB5402 Mouse Monoclonal 1:1,000
SCAMP1 (22) BD Biosciences 612087 Mouse Monoclonal 1:500
SV2C Santa Cruz Biotech sc-28957 Rabbit Polyclonal 1:500
VMAT2 Millipore AB1598P Rabbit Polyclonal 1:1,000
GluR2 Abcam ab40878 Rabbit Polyclonal 1:5,000
Homer1 B/C Millipore AB5877 Rat Polyclonal 1:1,000
NMDAR2B Millipore AB1557P Rabbit Polyclonal 1:1,000
PSD95 Cell Signaling 2507 Rabbit Polyclonal 1:1,000
SynGAP Sigma Aldrich S5437 Rabbit Polyclonal 1:1,000
CD68 (E-11) Santa Cruz Biotech sc-17832 Mouse Monoclonal 1:200
GFAP (2E1) BD Biosciences 556330 Mouse Monoclonal 1:500
14-3-3 ζ Millipore AB9746 Rabbit Polyclonal 1:3,000
14-3-3 ε (12) BD Biosciences 610543 Mouse Monoclonal 1:1,000
Synapsin 1 Abcam ab8 Rabbit Polyclonal 1:1,000
Annexin V Abcam ab14196 Rabbit Polyclonal 1:2,000
CRMP2 Abcam ab36201 Rabbit Polyclonal 1:2,000
αB crystalline Abcam ab13497 Rabbit Polyclonal 1:1,000
αFodrin Cell Signaling 2122 Rabbit Polyclonal 1:1,000
Stathmin Abcam ab47468 Rabbit Polyclonal 1:1,000
Immunofluorescence
LMP2/β1i Abcam ab3328 Rabbit Polyclonal 1:1,000
14-3-3 ζ (8C3) Abcam ab36777 Mouse Monoclonal 1:500
Synaptophysin (SVP-38) Sigma Aldrich S5768 Mouse Monoclonal 1:200
Table 1 Antibodies used in
immunoblots and immunofluo-
rescence microscopy
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freshly prepared unfrozen and cryoprotected frozen speci-
mens from the same decedent (not shown). Postsynaptic
protein markers were enriched about 6-fold in synaptosome
prepared from fresh tissue, frozen tissue, and cryoprotected
tissue; presynaptic markers were less markedly enriched
(Fig. 1). Glial cell markers, including glial fibrillary acidic
protein, were sharply depleted in the preparations. These
results are generally equivalent to those obtained using a
preparation from a fresh or frozen rodent brain (Dodd et al.
1981; Eshleman et al. 2001; Gray and Whittaker 1962;
Mash et al. 2002; Wood et al. 1996). Osmotic lysis of
human cerebrocortical synaptosomes produced further
protein enrichment (not illustrated), but we did not employ
osmotic lysis in order to prevent the release of membrane-
bound proteasome components.
Preliminary spot lists from the screening gels The yield of
synaptosome protein from brain homogenates and the time
and effort required to perform the isolation served to limit
the number of subjects that could be analyzed. The
proteomic analysis was designed to compare seven synap-
tosome pools that were produced from the isolates of 19
subjects. From the seven screening pools, seven compar-
isons were done; a total of 139 spots with at least a 2-fold
difference in optical density were identified. The prelimi-
nary “spot list” was reduced to 68 spots by eliminating
manually those spots that were too low in intensity or were
not present in at least two of the three gels. For the
remaining spots, the gel with the highest spot intensity was
selected, and the area was removed using a large-bore
pipette tip. Each spot was analyzed by mass spectrometry.
After MS analysis, 31 candidate proteins were identified
(Table 2).
Immunoblotting Nine promising protein candidates identi-
fied by mass spectrometry were evaluated in individual
synaptosome extracts by Western blotting. Three proteins
were significantly different in one or more of the HIV-
infected groups; another protein was changed marginally
(Fig. 2a). Synapsin 1b concentration was sharply decreased
in the HIV-positive subjects with high brain HIV-1 and
LMP7. 14-3-3ζ concentration was increased by 75% in the
subjects with high brain HIV-1 and LMP7 (p<0.01).
Synaptosome 14-3-3ε was increased about 2-fold in the
HIV-positive subjects with high HIV-1 and LMP7, as
compared to those with low HIV-1 (p<0.05). When the
protein concentrations were compared to HIV-1 concen-
trations in brain, CSF, and blood, Pearson correlation
coefficients were positive and significant for brain and
CSF HIV-1 loads (Table 3). Stathmin was marginally
decreased in the high HIV-1 group (Fig. 2c) and was
significantly correlated with brain HIV-1 (Table 3). Immu-
noblots confirmed that the IPS subunit LMP7 was increased
3-fold in synaptosome and whole cell preparations both
(Figs. 1 and 2a). Concentrations of six other proteins on the
original list of 31 candidates in Table 2 were not
significantly altered in the immunoblots (Fig. 2c).
Morphological localization with immunoproteasomes To
determine whether the altered synaptosomal proteins in
HIV/AIDS are histologically related to IPS subunits, we
performed dual localization using laser confocal microsco-
py. Immunoreactivities of 14-3-3ζ and the IPS subunit
LMP2 both were present in punctate neuronal and neuropil
markings that were typical of neocortical synapses. Coloc-
alization of 14-3-3ζ and LMP2 in these punctate synaptic
deposits was often observed (Fig. 3). Colocalizing proteins
were most obvious in the brains that contained a high HIV
RNA concentration and HIVE. It was not possible to
demonstrate a spatial relationship using synapsin 1b
staining because its concentration was sharply depressed
due to HIV-1 and difficult to detect histochemically (not
illustrated).
Discussion
This proteomic analysis focused on the synaptic compart-
ment because HIVE produces histological changes in the
synaptodendritic arbor (Masliah et al. 1997) and biochemical
changes in synaptic proteins (Gelman and Schuenke 2004).
Isolated nerve endings from humans infected with HIV-1
contained subtle and specific changes in their protein
composition. The concentrations of three synaptic proteins
were abnormal in brain fractions that were enriched in
synaptic nerve endings. The concentration of the presynaptic
protein synapsin 1b was sharply decreased in synaptosomes
from subjects with a high HIV-1 and immunoproteasome
concentration in brain neocortex. Stathmin had a statistically
marginal decrease and was negatively correlated with brain
HIV-1 load. The concentrations of 14-3-3ζ and 14-3-3ε were
significantly greater in the high brain HIV-1 group. A wide
range of pre- and postsynaptic marker proteins was not
affected by HIV-1 infection (Fig. 1), which illustrates that a
comprehensive decline of the entire synaptic protein reper-
toire did not occur.
We focused attention on the hypothesis that the multi-
catalytic proteinase known as the UPS might be correlative.
The UPS operates locally in the synaptic compartment and
exerts a strong and physiologically rapid influence on
synaptic protein concentrations (Yi and Ehlers 2005). It is
important, therefore, that the protein changes we observed
were correlated with induction of immunoproteasome
subunits (IPS) of the UPS (e.g., LMP7; Figs. 1 and 2a),
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2005). Indeed, the synaptosome protein changes were
related significantly to HIV-1 loads in brain tissue and
cerebrospinal fluid (Table 3). One of the proteins was
histologically colocalized with LMP7 in punctate neuronal
structures morphologically consistent with synapses
(Fig. 3). Using scarce specimens from human subjects,
these correlative results suggest that the IPS may be
involved with the local regulation of synaptic proteins in
HIV-1 infection. In turn, synaptosome protein changes
associated with IPS induction could lead to morphological
changes in the synaptodendritic arbor, which is correlated
with HIV-1-associated neurocognitive impairment (Masliah
et al. 1997).
Synapsin 1b is a phosphoprotein localized primarily in
presynaptic nerve terminals. It modulates the availability of
synaptic vesicles bound to cytoskeletal proteins and
controls neurotransmitter release in response to action
potentials (Evergren et al. 2007). Knockout mice lacking
synapsin genes have severe synaptic depression after
repetitive high stimulation; the protein probably plays a
key role in regulating the reserve pool of synaptic vesicles
Table 2 Identified proteins from synaptosome proteomic analysis
Protein Accession number Score CI% MW (kDa) PI Group comparison Fold change
Increased with high immunoproteasomes
14-3-3 Epsilon 119611033 74 99 21.0 5.7 B<D 2.21
14-3-3 Zeta 49119653 379 100 30.1 4.7 B<D; C<D 2.84; 2.19
α Fodrin 119608213 346 100 280.1 5.2 E<F; E<G 2.09; 2.31
β Tubulin 18088719 110 100 50.1 4.8 E<G 2.00
β-Actin 15277503 245 100 40.5 5.6 B<C; B<D 2.02; 2.34
Carbonic anhydrase II 119389514 56 51 29.2 6.8 B<D 2.04
Collapsin response mediator protein 2 62087970 173 100 68.6 5.9 B<D 2.07
Creatine kinase B 49457530 365 100 42.9 5.3 B<D; C<D 2.94; 2.00
Dynamin 1 123236791 58 68 96.2 6.3 B<D 2.00
Heat shock 70 kDa protein 1 147744565 150 100 70.3 5.5 B<D 2.00
Tropomyosin 3 114155146 374 100 29.1 4.8 B<D 2.18
Ubiquitin activating enzyme E1 35830 63 89 118.8 5.6 B<D 2.02
Ubiquitin carboxy-terminal hydrolase L1 4185720 155 100 23.4 5.3 B<D 2.00
Decreased with high immunoproteasomes
αB Crystallin 4503057 565 100 20.1 6.8 C>D −2.11
Aldolase A 4557305 369 100 39.9 8.3 E>G −2.76
Annexin V 809185 65 94 35.8 4.9 B>D −2.06
ATP synthase 15030240 256 100 59.9 9.1 E>G −2.25
Calmodulin 146386506 88 100 7.7 4.3 E>G −2.22
Chaperonin 10 4008131 155 100 10.6 9.4 E>F −2.03
Cytochrome c oxidase subunit VIb 4502985 133 100 10.4 6.5 B>D −2.65
Peroxiredoxin 2 32189392 479 100 22.0 5.7 B>D −2.33
Phosphoglycerate kinase 1 48145549 472 100 45.0 8.3 E>G −2.29
Stathmin 1 5031851 376 100 17.3 5.8 B>D −2.07
Transgelin 3 56549135 32 0 22.6 6.8 C>D; E>G −2.14; −2.00
Ubiquitin C 54300702 435 100 17.1 7.9 B>D −2.00
Increased with HIV infection without NPI or HIVE
Acyl coenzyme A dehydrogenase 10 119618373 66 95 54.4 9.1 A<B 2.00
Hemoglobin α2 22671717 341 100 15.3 8.7 A<B; B>C 2.07; 2.08
Myelin basic protein 49168552 80 100 17.3 11.1 B>C 2.13
Synapsin Ib 338649 60 80 74.1 9.9 A<B 2.13
Decreased with HIV infection without NPI or HIVE
Protein kinase C substrate 80K-H 48255891 75 99 60.1 4.3 A>B −2.01
Increased with HIVE
α Tubulin 109096484 61 84 46.8 5.0 F<G 2.01
98 J Neuroimmune Pharmacol (2010) 5:92–102(Rosahl et al. 1995; Chi et al. 2001; Gitler et al. 2004;S u ne t
al. 2006). Its concentration has been noted to decrease in
senile dementia of the Alzheimer type, although this could
reflect a nonspecific loss of whole synapses instead of a
specific change within viable nerve endings, as suggested for
HIV/AIDS (Ho et al. 2001; Qin et al. 2004; Sze et al. 2000).
The decrease of synapsin 1b in nerve endings associated
with HIV-1 infection suggests that there is abnormal
regulation of the reserve pool of presynaptic vesicles of
brain neocortex, analogous to what happens in synapsin 1
knockout mice. Physiologically, knocking out synapsin 1
gene (Gitler et al. 2004), inhibiting the UPS (Fonseca et al.
2006), and increased LMP7 and IPS synthesis (Gavilan et al.
2009; Maher et al. 2006) all produce long-term synaptic
depression (LTD). When synapsin 1 is downregulated in
LTD, the effect is strictly dependent on normally functioning
active sites of the UPS (Fioravante et al. 2008). Our results
using human synaptosomes support the suggested relation-
ship between decreased concentration of synapsin 1b and the
UPS (i.e., the increased immunoproteasome active site,
LMP7; Fig. 2a). The potential role of HIV-1 on posttran-
scriptional regulation of synaptosomal synapsin 1 by the
UPS and its potential relationship to LTD are aspects that
warrant further elucidation in the future. A degradation
pathway for synapsin 1 via calcium-activated calpain
proteases also might be involved in synapsin downregulation
(Murrey et al. 2006).
The decrease of stathmin in synaptosomes was marginal
statistically, yet worthy of notice because unlike synapsin, it
can be localized in postsynaptic dendrites. Stathmin is a
phosphoprotein that plays roles in synaptic physiology,
axon aging, and maintenance. It regulates the balance
between polymerization and depolymerization of micro-
tubules, which is critical for elongation of dendritic arbors.
Knockdown of stathmin increases microtubule stability and
decreases dendritic elongation (Grenningloh et al. 2004).
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Fig. 2 Immunoblots of synaptosomes prepared from frontal neocortex
from all 19 human subjects. Comparison groups are according to
status of HIV-1 infection, neocortical HIV-1 RNA load (low and high),
and neocortical immunoproteasome subunit expression (low and
high). a Subjects with high HIV-1 loads had significantly more
synaptosome LMP7 as compared to the other groups. b Synapsin 1b
concentration was decreased in subjects with high HIV-1 load and
abundant LMP7; 14-3-3 zeta and 14-3-3 epsilon were increased with
high HIV-1 and LMP7. c The decreased stathmin in subjects with high
HIV-1 and LMP7 was marginal (p<0.1). Concentrations of HIV-1
RNA in brain cortex in the three respective groups (log10 copies per
gram of wet weight) were 0±0, 2.77±1.50, and 4.81±0.48 (t test: p=
0.0000055, low versus high). The values for the IPS subunit LMP7
concentration in the three groups were 1.00±0.79, 2.02±1.02, and
4.03±2.15 in relative density units (t test: p=0.0315, low versus high).
Six other candidate protein species tested were not different statistically.
IPS neocortical immunoproteasome concentration. Mean±one standard
deviation. *p<0.05; **p<0.01
J Neuroimmune Pharmacol (2010) 5:92–102 99Stathmin knockout mice display a defect in maintaining
axon stability during aging (Liedtke et al. 2002). The
decrease of stathmin concentration in synaptosomes in
HIV-1 infection could modify the synaptodendritic arbor
(Masliah et al. 1997) and axon integrity (Giometto et al.
1997) via stabilization of microtubule assemblies and
decreased turnover of microtubule proteins.
The 14-3-3 protein family is highly abundant in the
brain. Its members modulate protein interactions and
regulate many neuronal processes (Berg et al. 2003a;
Kjarland et al. 2006), including synaptic plasticity (Dai
and Murakami 2003), neurotransmitter synthesis (Ichimura
et al. 1987; Kleppe et al. 2001), and synaptic ion channel
function and localization (Bunney et al. 2002; Rajan et al.
2002; Suginta et al. 2001; Zhou et al. 1999). Given their
widespread functions, it is difficult to predict the functional
impact of having increased 14-3-3 proteins in HIV-1
infection. Its ion channel activation properties can modify
long-term potentiation and LTD (Zhou et al. 1999), similar
to what happens when synapsin 1 and stathmin are
perturbed. The concentration of 14-3-3 proteins is linked
to several neurodegenerative diseases, including HAND.
Demented patients with spongiform encephalopathies have
increased concentrations of 14-3-3 proteins in the CSF
(Berg et al. 2003a; Kenney et al. 2000; Lemstra et al.
2000); these proteins accumulate neuropathologically in
characteristic Prion Protein (PrP) plaques (Richard et al.
2003). 14-3-3 proteins localize within neurons that contain
neurofibrillary tangles, a key neuropathological change in
senile dementia (Hashiguchi et al. 2000; Umahara et al.
2004). They also are present in Lewy bodies, which are the
pathological hallmark of Parkinson disease and Lewy body
dementias (Berg et al. 2003b; Kawamoto et al. 2002). 14-3-
3 proteins epsilon, gamma, and zeta isoforms (but not beta,
eta, or tau) have been reported to be increased in the CSF of
patients with HIV/AIDS, primarily those with HIV-
associated dementia or cytomegalovirus infection (Miller
et al. 2000; Wakabayashi et al. 2001). In macaques infected
with simian immunodeficiency virus (SIV), 14-3-3 proteins
in the CSF were increased primarily in animals with high
SIV loads in brain (Helke et al. 2005). Rodents infected
with a murine immunodeficiency virus had decreased 14-3-
3ζ concentration in whole hippocampus (CSF not mea-
sured; Takahashi et al. 2007). Since 14-3-3ζ is involved in
Table 3 Synaptosome proteins correlated with HIV-1 concentration
Synaptosome protein
concentration
(relative intensity)
Correlation with HIV-1 RNA concentration
Brain (log10
copies/g wet
weight)
CSF (log10
copies/mL)
Plasma
(log10
copies/mL)
LMP7 r=0.5215 r=0.5219 r=0.5147
p<0.0264* p<0.0459* p<0.0288*
Synapsin 1 r=−0.4820 r=−0.6610 r=−0.5099
p<0.0428* p<0.0072* p<0.0306*
Stathmin r=−0.4867 r=−0.4693 r=−0.3678
p<0.0404* p<0.0775 p<0.1331
14-3-3ε r=0.4763 r=0.5296 r=0.2619
p<0.0456* p<0.0422* p<0.2735
14-3-3η r=0.2674 r=0.0319 r=0.0020
p<0.2833 p<0.2458 p<0.9937
n=19. Asterisk denotes statistically significant p value. Brain
measurements were performed using frontal neocortex
r correlation coefficient, CSF cerebrospinal fluid, Plasma blood
plasma, HIV-1 human immunodeficiency virus type 1
Fig. 3 Confocal immunofluorescence microscopy for 14-3-3ζ (red)
and the immunoproteasome subunit marker LMP2 (green) in a subject
with HIVencephalitis and high concentrations of these proteins in the
synaptosome preparation. Punctate deposits of both proteins outline
the distinct shape of a pyramidal neocortical neuron and surrounding
neuropil. The perikaryon and neuropil both contain deposits of these
proteins, which morphologically resemble synaptic densities. Arrows
in the large bottom panel denote foci where the antigens are
colocalized in the merged image. Attempts to localize synapsin 1
were not successful technically because its concentration was sharply
decreased in HIV encephalitis. Scale bar=10 μm
100 J Neuroimmune Pharmacol (2010) 5:92–102synaptic plasticity and neurotransmitter release, its anoma-
lous concentrations in HIV-1-infected synaptosomes may
reflect changes in the synaptodendritic arbor, which occur
primarily with high HIV-1 loads in the brain (Masliah et al.
1997). Regulation of ion channels by 14-3-3 species can
produce acquired neuronal channelopathies, which have
been documented to occur in HAND (Gelman et al. 2004).
Summary Proteomics using isolated nerve endings has
revealed novel synaptic protein changes in HIV-1-infected
human subjects. Synapsin 1b, 14-3-3ζ,1 4 - 3 - 3 ε, and stath-
min concentrations were selectively perturbed and were
correlated with brain HIV-1 load and altered expression of
UPS subunits. The regulated proteins play key roles in
neurotransmitter release, dendritic morphology, synaptic
plasticity, and long-term synaptic depression. Their abnormal
concentrations in the synaptic compartment could be linked
to morphological changes in the synaptodendritic arbor and
neuronal channelopathies in HAND. Physiological regula-
tion of proteins by the UPS locally within the synaptic
compartment is a well-documented pathway experimentally;
these new results with human nerve endings support the
suggestion that the UPS could be involved in HIV-associated
changes in synaptic proteins. Alternate screening strategies
could reveal still other abnormal protein species of the
synaptic proteome due to HIV-1, as many proteins species
were not within range of the chosen technique.
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